Life Sciences/Biotech

Health Insurance Delay Raises Questions For Insurers, Regulators

LANSING - Insurers and the Department of Financial and Insurance Services were still working Thursday to determine the effect of President Barack Obama's executive order allowing those with current health policies to retain them for at least another year. The executive order, issued after a backlash over a spate of policy cancelation notices, would allow

By |2013-11-15T00:00:00-05:00November 15th, 2013|Archive, Life Sciences/Biotech|

24,000 Apply, 1,329 Complete Enrollment In Health Insurance Via Exchange In Michigan

LANSING - Just 1,329 Michiganders have completed enrollment in a health insurance plan through the deeply troubled federal exchange in the first month of operations, a pace that would put enrollment numbers a whopping 95 percent below the forecast for enrollment in the first year. The U.S. Department of Health and Human Services released the

By |2013-11-13T00:00:00-05:00November 13th, 2013|Archive, Life Sciences/Biotech|

Caswell Aims To Improve Generic Drug Pricing For Pharmacies

LANSING - Sen. Bruce Caswell said Wednesday that the health care industry is complicated, but he's hoping his bill allowing pharmacists to receive up to three national drug codes from pharmaceutical benefits managers could bring some clarity to the industry's drug pricing. "The core issue here was to create, for pharmacies across the state, the

By |2013-11-06T00:00:00-05:00November 6th, 2013|Archive, Life Sciences/Biotech|

GVSU Board Agrees To Buy 11 Acres In Grand Rapids For Health Campus

DETROIT - The Grand Valley State University board, meeting Friday at its new Detroit Center near Comerica Park, approved the purchase of 11 acres of land near downtown Grand Rapids to expand the university's health campus at the east end of Grand Rapids' multi-billion-dollar Medical Mile. The university already owns four acres of property adjacent

By |2013-11-04T00:00:00-05:00November 4th, 2013|Archive, Life Sciences/Biotech|

Great Lakes Health Information Exchange, Michigan Health Connect Partner

GRAND RAPIDS - More Michigan physicians and other healthcare providers than ever before will be able to share medical records electronically under an agreement between the Great Lakes Health Information Exchange and Michigan Health Connect. The collaboration between the state?s two largest providers of health information exchange means that medical professionals treating about half the

By |2013-10-29T00:00:00-04:00October 29th, 2013|Archive, Life Sciences/Biotech|

Enzo Life Sciences Debuts Sclerostin Screening System

ANN ARBOR - Enzo Life Sciences has expanded its portfolio of drug discovery screening platforms with the introduction of the new Leading Ligh Sclerostin-LRP Screening System. The Leading Light Sclerostin-LRP Screening System was developed to meet the market need for a simple, sensitive biochemical screening assay for detection of sclerostin inhibitors (antagonists of the Wnt

By |2013-10-23T00:00:00-04:00October 23rd, 2013|Archive, Life Sciences/Biotech|

Expert Says 2013 Sets Stage For Several Solid Years For Life Sciences Investments

KALAMAZOO - 2013 has been one of the strongest years in many for biotech and medical device companies to go public, a California venture capitalist said Tuesday at the MichBio Expo. Mike Carusi, General Partner of Advanced Technology Partners based in Palo Alto, California. Carusi is a General Partner and Team Leader for Lightstone Ventures,

By |2013-10-17T00:00:00-04:00October 17th, 2013|Archive, Life Sciences/Biotech|

2013 MichBio Expo In Kalamazoo Set For Oct. 15-16

KALAMAZOO ? The 2013 MichBio Expo & Conference is set for Oct. 15-16 at the Radisson Plaza Hotel in downtown Kalamazoo. The 2013 MichBio Expo will present the annual Emerging Biosciences Showcase and will feature pitches from 9 early stage, innovative bioscience start-ups across multiple industry sectors. MichBio is now accepting applications for the Emerging

By |2013-10-11T00:00:00-04:00October 11th, 2013|Archive, Life Sciences/Biotech|

Rubicon Genomics Product Helps Track Resistance Of Cancer Drugs

ANN ARBOR ? Rubicon Genomics reported that its ThruPLEXTM-FD Prep Kits contributed to the success of a breakthrough study recently published in Nature1 that showed that genomic data extracted from the plasma of cancer patients can be used to track drug resistance and potentially guide treatment. The proof-of-principle study showed that by sequencing tumor exomes

By |2013-10-01T00:00:00-04:00October 1st, 2013|Archive, Life Sciences/Biotech|